Related Experiment Video
Updated: Sep 11, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
NetWalkRank: Cancer Driver Gene Prioritization in Multiplex Gene Regulatory Networks by a Random Walk Approach
Abstract:
Finding and prioritizing cancer driver genes (CDGs) that disrupt normal cell functionality and contribute to cancer occurrence and development is a significant challenge in oncology. Integrating multiple information pertaining to the characteristics of each gene at different stages of the disease and incorporating multiple steps as individual layers in the model provides a more comprehensive understanding of each node or gene. Thus, it is reasonable to organize them into multiplex gene regulatory networks (GRNs). In this work, we present a network-based framework called NetWalkRank, for prioritizing CDGs in the multiplex GRNs with gene expression profiling data. The framework applies the concept of network propagation to calculate the relative impact of each gene in spreading abnormality throughout the multiplex GRNs. It was employed to give priority to the driver genes of hepatocellular carcinoma (HCC) in humans. The performance of NetWalkRank was demonstrated through the ranks and classifications assigned to the known CDGs, which validated its effectiveness. To showcase the predictive capabilities of our proposed framework, we trained a random forest model that utilizes the obtained scores to accurately predict CDGs. We compared the advantage and efficiency of our method with other well-known driver gene ranking methods through numerical experiments. The findings show that the usage of GRNs across various steps of multiplex networks in prioritizing and predicting CDGs is significant, as demonstrated by the efficiency and effectiveness of NetWalkRank.
Insights
Identifying cancer driver genes (CDGs) is crucial for oncology. NetWalkRank prioritizes CDGs in multiplex gene regulatory networks (GRNs) using network propagation, showing significant effectiveness in predicting hepatocellular carcinoma driver genes.
Area of Science:
- Oncology
- Bioinformatics
- Systems Biology
Background:
- Identifying cancer driver genes (CDGs) is essential for understanding cancer development.
- Existing methods often struggle to integrate complex, multi-stage gene information.
- Multiplex gene regulatory networks (GRNs) offer a promising approach to model gene interactions.
Purpose of the Study:
- To develop a novel network-based framework, NetWalkRank, for prioritizing CDGs.
- To leverage multiplex GRNs and gene expression data for enhanced CDG identification.
- To validate NetWalkRank's effectiveness in prioritizing hepatocellular carcinoma (HCC) driver genes.
Main Methods:
- Constructing multiplex gene regulatory networks (GRNs) integrating multi-stage gene information.
- Applying network propagation within the multiplex GRNs to assess gene abnormality spread.
- Utilizing gene expression profiling data as input for the network analysis.
- Training a random forest model with NetWalkRank scores for CDG prediction.
Main Results:
- NetWalkRank effectively prioritized known CDGs for hepatocellular carcinoma (HCC).
- The framework demonstrated superior performance compared to existing driver gene ranking methods.
- A random forest model trained on NetWalkRank scores achieved accurate CDG prediction.
- Numerical experiments confirmed the efficiency and effectiveness of the proposed method.
Conclusions:
- NetWalkRank provides a robust framework for prioritizing cancer driver genes.
- Integrating information across multiplex GRNs significantly enhances CDG identification and prediction.
- The method holds promise for advancing cancer research and therapeutic strategies.
More Related Videos
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Survival Analysis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...